Eric Crombez
CIK: 0001653052
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- May 15, 2026ABEO
ABEONA THERAPEUTICS INC.
Sale(S)Direct26.1K shares at avg. $5.53$145K - May 5, 2026RARE
Ultragenyx Pharmaceutical Inc.
Sale(S)Direct344 shares at avg. $24.96$9K - Apr 16, 2026RARE
Ultragenyx Pharmaceutical Inc.
Award(A)Direct34.7K shares- - Mar 2, 2026RARE
Ultragenyx Pharmaceutical Inc.
Sale(S)Direct7K shares at avg. $22.80$160K - Mar 1, 2026RARE
Ultragenyx Pharmaceutical Inc.
Award(A)Direct11.6K shares- - Feb 2, 2026ABEO
ABEONA THERAPEUTICS INC.
Sale(S)Direct16.3K shares at avg. $5.09$83K - Jan 26, 2026ABEO
ABEONA THERAPEUTICS INC.
Award(A)Direct37.3K shares- - Aug 14, 2025ABEO
ABEONA THERAPEUTICS INC.
Sale(S)Direct4.7K shares at avg. $6.93$33K - May 5, 2025RARE
Ultragenyx Pharmaceutical Inc.
Sale(S)Direct520 shares at avg. $39.24$20K - Apr 21, 2025RARE
Ultragenyx Pharmaceutical Inc.
Sale(S)Direct242 shares at avg. $35.11$8K - Mar 3, 2025RARE
Ultragenyx Pharmaceutical Inc.
Sale(S)Direct8.9K shares at avg. $42.10$377K - Mar 1, 2025RARE
Ultragenyx Pharmaceutical Inc.
Award(A)Direct16.8K shares- - Mar 1, 2025RARE
Ultragenyx Pharmaceutical Inc.
Award(A)Direct15K shares- - Jan 31, 2025ABEO
ABEONA THERAPEUTICS INC.
Award(A)Direct36.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 15, 2026 |  ABEO ABEONA THERAPEUTICS INC. | Sale(S) | 26,143 | $5.53 | $144,636 | Direct |
| May 5, 2026 |  RARE Ultragenyx Pharmaceutical Inc. | Sale(S) | 344 | $24.96 | $8,586 | Direct |
| Apr 16, 2026 | RARE Ultragenyx Pharmaceutical Inc. | Award(A) | 34,674 | - | $0 | Direct |
| Mar 2, 2026 | RARE Ultragenyx Pharmaceutical Inc. | Sale(S) | 7,029 | $22.80 | $160,261 | Direct |
| Mar 1, 2026 | RARE Ultragenyx Pharmaceutical Inc. | Award(A) | 11,643 | - | $0 | Direct |
| Feb 2, 2026 | ABEO ABEONA THERAPEUTICS INC. | Sale(S) | 16,284 | $5.09 | $82,895 | Direct |
| Jan 26, 2026 | ABEO ABEONA THERAPEUTICS INC. | Award(A) | 37,313 | - | $0 | Direct |
| Aug 14, 2025 | ABEO ABEONA THERAPEUTICS INC. | Sale(S) | 4,718 | $6.93 | $32,683 | Direct |
| May 5, 2025 | RARE Ultragenyx Pharmaceutical Inc. | Sale(S) | 520 | $39.24 | $20,405 | Direct |
| Apr 21, 2025 | RARE Ultragenyx Pharmaceutical Inc. | Sale(S) | 242 | $35.11 | $8,497 | Direct |
| Mar 3, 2025 | RARE Ultragenyx Pharmaceutical Inc. | Sale(S) | 8,945 | $42.10 | $376,585 | Direct |
| Mar 1, 2025 | RARE Ultragenyx Pharmaceutical Inc. | Award(A) | 16,813 | - | - | Direct |
| Mar 1, 2025 | RARE Ultragenyx Pharmaceutical Inc. | Award(A) | 14,971 | - | - | Direct |
| Jan 31, 2025 | ABEO ABEONA THERAPEUTICS INC. | Award(A) | 36,101 | - | - | Direct |
1-14 of 14 transactions
About Crombez Eric
Crombez Eric (SEC CIK 0001653052) files insider reports with the SEC as Director of ABEONA THERAPEUTICS INC. (ABEO) and EVP and Chief Medical Officer of Ultragenyx Pharmaceutical Inc. (RARE).
Signal8 holds 10 ownership filings by Crombez Eric, all Form 4s, filed between Feb 3, 2025 and May 15, 2026. Those filings report 14 transactions, from Jan 31, 2025 to May 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Crombez Eric's filings is in NOVATO, CA.
Recent filings by Crombez Eric
- May 15, 2026: Open-market sale of ABEO shares (Form 4, code S).
- May 5, 2026: Open-market sale of RARE shares (Form 4, code S).
- Apr 16, 2026: Grant or award of RARE shares (Form 4, code A).
- Mar 2, 2026: Open-market sale of RARE shares (Form 4, code S).
- Mar 1, 2026: Grant or award of RARE shares (Form 4, code A).
Other insiders filing for ABEONA THERAPEUTICS INC. (ABEO)
- Seshadri Vishwas, Chief Executive Officer
- Vazzano Joseph Walter, Chief Financial Officer
- O'Malley Brendan M., SVP, Chief Legal Officer
- Vasanthavada Madhav, Chief Commercial Officer
- Alvino Mark, Director
- Alland Leila, Director